**Core Concept**
Sickle cell trait, a hemoglobinopathy characterized by the presence of both sickle hemoglobin (HbS) and normal hemoglobin (HbA) in red blood cells, increases the risk of specific renal and urinary tract malignancies due to chronic hemolysis and sickling within the renal medulla.

**Why the Correct Answer is Right**
Renal medullary carcinoma (RMC) is a highly aggressive and rare malignancy that predominantly affects individuals with sickle cell trait. The pathogenesis of RMC is linked to the chronic sickling process within the renal medulla, which leads to fibrosis, inflammation, and eventually, the development of malignant cells. RMC typically presents as a renal mass in the upper pole of the kidney, often with associated hematuria and flank pain.

**Why Each Wrong Option is Incorrect**
**Option A:** Non-Hodgkin lymphoma is not specifically associated with sickle cell trait and is more commonly linked to immune system dysregulation or infections.

**Option B:** Angiomyolipoma is a benign renal tumor, often associated with tuberous sclerosis complex, and is not a typical complication of sickle cell trait.

**Option D:** Transitional cell carcinoma, a type of urothelial carcinoma, is more commonly linked to smoking and environmental exposures rather than sickle cell trait.

**Clinical Pearl / High-Yield Fact**
Sickle cell trait increases the risk of renal medullary carcinoma, highlighting the importance of regular renal surveillance in individuals with sickle cell trait, particularly those with a family history of malignancy.

**✓ Correct Answer: C. Renal medullary carcinoma**